您的位置: 首页 > 农业专利 > 详情页

NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF
专利权人:
AbbVie Deutschland GmbH &; Co. KG;AbbVie Inc.
发明人:
Mario Mezler,Achim Moeller,Reinhold Mueller,Bernhard K. Mueller,Tariq Ghayur,Eve H. Barlow,Martin Schmidt,Axel Meyer,Nicole Teusch
申请号:
US16055659
公开号:
US20190233510A1
申请日:
2018.08.06
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The subject invention relates to isolated proteins, particularly monoclonal antibodies, which bind to the Nogo-66 receptor. Specifically, these antibodies have the ability to inhibit the binding of the natural ligand of the Nogo-66 receptor and neutralize the Nogo-66 receptor. These antibodies or portions thereof of the invention are useful for detecting NgR and for inhibiting NgR activity, for example in a human suffering from a disorder in which NgR or Nogo-66 activity is detrimental.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充